The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kathiresan Sekar since 2021.
This trader's CIK number is 1864112.
At the time of last reporting, Kathiresan Sekar was the Chief Executive Officer of Verve Therapeutics, Inc.. (stock ticker symbol VERV).
Also see all insider trading activities at Verve Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | VERV | 0 | $0 | 9,822 | $40,761 | 33,000 | $0 |
| 2024 | VERV | 0 | $0 | 0 | $0 | 30,000 | $86,100 |
| 2022 | VERV | 0 | $0 | 151,870 | $4,766,563 | 221,544 | $411,063 |
| 2021 | VERV | 2,500 | $47,500 | 162,693 | $6,472,052 | 162,693 | $226,142 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-01 | VERV | Option Ex | 33,000 | .00 | 0 |
| 2025-04-02 | VERV | Sale | 9,822 | 4.15 | 40,761 |
| 2024-06-28 | VERV | Option Ex | 30,000 | 2.87 | 86,100 |
| 2022-10-03 | VERV | Option Ex | 50,000 | 1.39 | 69,500 |
| 2022-10-03 | VERV | Sale | 50,000 | 34.04 | 1,701,950 |
| 2022-08-10 | VERV | Option Ex | 50,000 | 1.39 | 69,500 |
| 2022-08-10 | VERV | Sale | 50,000 | 29.90 | 1,495,000 |
| 2022-07-19 | VERV | Option Ex | 50,000 | 1.39 | 69,500 |
| 2022-07-19 | VERV | Sale | 50,000 | 29.90 | 1,495,000 |
| 2022-03-18 | VERV | Option Ex | 69,674 | 2.87 | 199,964 |
| 2022-01-04 | VERV | Option Ex | 1,870 | 1.39 | 2,599 |
| 2022-01-04 | VERV | Sale | 1,870 | 39.90 | 74,613 |
| 2021-12-27 | VERV | Option Ex | 42,000 | 1.39 | 58,379 |
| 2021-12-28 | VERV | Option Ex | 6,693 | 1.39 | 9,303 |
| 2021-12-27 | VERV | Sale | 42,000 | 41.16 | 1,728,678 |
| 2021-12-28 | VERV | Sale | 6,693 | 39.90 | 267,050 |
| 2021-12-23 | VERV | Option Ex | 57,000 | 1.39 | 79,230 |
| 2021-12-22 | VERV | Option Ex | 57,000 | 1.39 | 79,230 |
| 2021-12-23 | VERV | Sale | 57,000 | 39.90 | 2,274,300 |
| 2021-12-22 | VERV | Sale | 57,000 | 38.63 | 2,202,024 |
| 2021-06-21 | VERV | Buy | 2,500 | 19.00 | 47,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kathiresan Sekar (Chief Executive Officer of Verve Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.